140 related articles for article (PubMed ID: 8262674)
1. Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti FO; Mancuso S
Int J Cancer; 1994 Jan; 56(1):26-30. PubMed ID: 8262674
[TBL] [Abstract][Full Text] [Related]
2. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
[TBL] [Abstract][Full Text] [Related]
4. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.
Scambia G; Benedetti-Panici P; Ferrandina G; Distefano M; Salerno G; Romanini ME; Fagotti A; Mancuso S
Br J Cancer; 1995 Aug; 72(2):361-6. PubMed ID: 7640219
[TBL] [Abstract][Full Text] [Related]
6. The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas.
Gul AE; Keser SH; Barisik NO; Kandemir NO; Cakir C; Sensu S; Karadayi N
Diagn Pathol; 2010 Feb; 5():13. PubMed ID: 20167054
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma.
Niikura H; Sasano H; Matsunaga G; Watanabe K; Ito K; Sato S; Yajima A
Hum Pathol; 1995 Aug; 26(8):892-6. PubMed ID: 7635451
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
9. Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors.
Scambia G; Panici PB; Bellantone R; Doglietto GB; Sofo L; Ferrandina G; Ratto C; Bossola M; Crucitti F; Spagnolo LC
J Surg Oncol; 1991 Nov; 48(3):183-7. PubMed ID: 1943115
[TBL] [Abstract][Full Text] [Related]
10. [Epidermal growth factor receptors and their ligands in endometrial carcinoma: correlation with clinico-morphologic factors and steroid receptors].
Gershtein ES; Bocharova LB; Ermilova VD; Laktionov KP; Kushlinskiĭ
Vopr Onkol; 2000; 46(2):180-6. PubMed ID: 10853417
[TBL] [Abstract][Full Text] [Related]
11. Steroid hormone receptor content and lymph node status in endometrial cancer.
Morris PC; Anderson JR; Anderson B; Buller RE
Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53, bcl-2 and EGFR in carcinoma of the endometrium.
Athanassiadou P; Petrakakou E; Liossi A; Nakopoulou L; Zerva C; Dimopoulos A; Athanassiades P
Acta Cytol; 1999; 43(6):1039-44. PubMed ID: 10578976
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of hormone receptors in endometrial cancer.
Creasman WT
Cancer; 1993 Feb; 71(4 Suppl):1467-70. PubMed ID: 8431882
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of EGFR in invasive breast cancer.
Quintela I; Corte MD; Allende MT; Vazquez J; Rodríguez JC; Bongera M; Lamelas M; Gonzalez LO; Vega A; García-Muñiz JL; Astudillo A; Vizoso F
Oncol Rep; 2005 Dec; 14(6):1655-63. PubMed ID: 16273272
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of tumor content of epidermal growth factor receptor in breast cancer].
Mulero M; Fernández Raigoso P; Vázquez J; Lamelas ML; Corte D; Allende MT; Rodríguez JC; Vizoso F
Rev Esp Med Nucl; 2003 Nov; 22(6):386-94. PubMed ID: 14588231
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the sensitivity of endometrial cancer cells to epidermal growth factor and steroid hormones.
Gershtein ES; Shatskaya VA; Kostyleva OI; Ermilova VD; Kushlinsky NE; Krasil'nikov MA
Cancer; 1995 Dec; 76(12):2524-9. PubMed ID: 8625080
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma.
Vecek N; Nola M; Marusić M; Ilić J; Babić D; Petrovecki M; Nikolić S; Marinović T; Jukić D; Vecek N
Acta Obstet Gynecol Scand; 1994 Oct; 73(9):730-3. PubMed ID: 7976251
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Shen XM; Li HG; Chen LH; Wang XY; Luo X; Lin ZQ; Jiang GY
Pathol Res Pract; 2012 Dec; 208(12):730-5. PubMed ID: 23122929
[TBL] [Abstract][Full Text] [Related]
19. Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer.
Lukes AS; Kohler MF; Pieper CF; Kerns BJ; Bentley R; Rodriguez GC; Soper JT; Clarke-Pearson DL; Bast RC; Berchuck A
Cancer; 1994 May; 73(9):2380-5. PubMed ID: 7909491
[TBL] [Abstract][Full Text] [Related]
20. 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion.
Lindahl B; Fernö M; Gullberg B; Norgren A; Willén R
Anticancer Res; 1992; 12(2):409-12. PubMed ID: 1580559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
